Familial Adenomatous Polyposis (FAP) in 9 Hispanic women

Por Ricker, Charite, Ault, Glenn, El-Khoureiy, Anthony, Iqbal, Syma, Spicer, Darcy, Lenz, Heinz-Josef
Publicado em 2010

Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II Southwest Oncology Group Study (S0415)

Por Gold, Philip J., Goldman, Bryan, Iqbal, Syma, Leichman, Lawrence P., Zhang, Wu, Lenz, Heinz-Josef, Blanke, Charles D.
Publicado em 2010

A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors

Por Iqbal, Syma, Lenz, Heinz-Josef, Gandara, David R., Shibata, Stephen I., Groshen, Susan, Synold, Timothy W., Newman, Edward M.
Publicado em 2013

Gender-Related Survival Differences Associated With Polymorphic Variants of Estrogen Receptor Beta (ERβ) in Patients with Metastatic Colon Cancer

Por Press, Oliver A., Zhang, Wu, Gordon, Michael A., Yang, Dongyun, Haiman, Christopher A., Azuma, Mizutomo, Iqbal, Syma, Lenz, Heinz-Josef
Publicado em 2010

A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group Study S0202

Por Iqbal, Syma, Rankin, Cathryn, Lenz, Heinz-Josef, Gold, Philip J., Ahmad, Syed A., El-Khoueiry, Anthony B., Messino, Michael J., Holcombe, Randall F., Blanke, Charles D.
Publicado em 2011

Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin

Por Gordon, Michael A, Zhang, Wu, Yang, Dongyun, Iqbal, Syma, El-Khouiery, Anthony, Nagashima, Fumio, Lurje, Georg, Labonte, Melissa, Wilson, Peter, Sherrod, Andy, Ladner, Robert D, Lenz, Heinz-Josef
Publicado em 2011

Dual blockade of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: phase Ib and randomized phase...

Por Philip, Philip A., Goldman, Bryan, Ramanathan, Ramesh K., Lenz, Heinz-Josef, Lowy, Andrew M., Whitehead, Robert P., Wakatsuki, Takeru, Iqbal, Syma, Gaur, Rakesh, Benedetti, Jacqueline K., Blanke, Charles D.
Publicado no Cancer (2014)

Phase 2 Study of MK-2206, an Allosteric Inhibitor of AKT, as Second-Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer: A SWOG Cooperative Group Trial (S1005)

Por Ramanathan, Ramesh K., McDonough, Shannon L., Kennecke, Hagen F., Iqbal, Syma, Baranda, Joaquina C., Seery, Tara E., Lim, Howard J., Hezel, Aram F., Vaccaro, Gina M., Blanke, Charles D.
Publicado no Cancer (2015)

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarc...

Por Leichman, Lawrence P., Goldman, Bryan H., Bohanes, Pierre O., Lenz, Heinz J., Thomas, Charles R., Billingsley, Kevin G., Corless, Christopher L., Iqbal, Syma, Gold, Philip J., Benedetti, Jacqueline K., Danenberg, Kathleen D., Blanke, Charles D.
Publicado em 2011

Prognostic impact of c-MET polymorphism on clinical outcome in loco-regional gastric cancer patients

Por Sunakawa, Yu, Wakatsuki, Takeru, Yang, Dongyun, Zhang, Wu, Ning, Yan, Stintzing, Sebastian, Stremitzer, Stefan, Yamauchi, Shinichi, Sebio, Ana, El-khoueiry, Rita, Iqbal, Syma, Afsaneh, Barzi, Gerger, Armin, Stotz, Michael, Azuma, Mizutomo, Watanabe, Masahiko, Koizumi, Wasaburo, Lenz, Heinz-Josef
Publicado no Pharmacogenet Genomics (2014)

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

Por Rubinson, Douglas A., Hochster, Howard S., Ryan, David P., Wolpin, Brian M., McCleary, Nadine Jackson, Abrams, Thomas A., Chan, Jennifer A., Iqbal, Syma, Lenz, Heinz J., Lim, Dean, Rose, Jeffrey, Bekaii-Saab, Tanios, Chen, Helen X., Fuchs, Charles S., Ng, Kimmie
Publicado em 2013